Importance The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) threatens global public health. The …

Abstract Background Coronavirus disease 2019 (COVID-19) is a global pandemic with no
licensed vaccine or specific antiviral agents for therapy. Little is known about the longitudinal …

The emerging coronavirus disease 2019 (COVID-19) has become a serious global public
health threat. With more and more recovered patients, it is urgently needed for evaluation of …

Background The COVID-19 pandemic caused by SARS-CoV-2 coronavirus threatens global
public health. Currently, neutralizing antibodies (NAbs) versus this virus are expected to …

ABSTRACT Coronavirus disease 2019 (COVID-19) has a wide spectrum of disease severity
from mild upper respiratory symptoms to respiratory failure. The role of neutralizing antibody …

In order to support vaccine development, and to aid convalescent plasma therapy, it would
be important to understand the kinetics, timing and persistence of SARS-CoV-2 neutralizing …

Background The characteristics of neutralizing antibodies (NAbs) and antibody against
major antigen proteins related to clinical outcomes in severe coronavirus disease 2019 …

Methods| Healthy adults who reported no SARS-CoV-2 vaccination were recruited via 1
public Twitter post and 1 public Facebook advertisement between September 11, 2021, and …

Background COVID-19 is a pandemic with no specific antiviral treatments or vaccines. The
urgent needs for exploring the neutralizing antibodies from patients with different clinical …

COVID-19 patients exhibit differential disease severity after SARS-CoV-2 infection. It is
currently unknown as to the correlation between the magnitude of neutralizing antibody …